United States· US:73070-203_ec67820c-4008-4894-b933-34b28704221d

Insulin Aspart Protamine and Insulin Aspart

A insulin aspart product containing insulin aspart, registered in United States by Novo Nordisk Pharma, Inc.. The same ATC class is registered in 11 of our 19 countries.

In shortageATC A10AD05US label

Checked against FDA National Drug Code directory (United States) on June 3, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about insulin aspartAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin aspart is registered in 11 of 19 countries.

Countries holding a registration under ATC A10AD05 (insulin aspart), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
7 of them publish a price we can compare per daily dose

Search insulin aspart products by name

Insulin aspart · ATC A10AD05

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: insulin aspart
Manufacturer: Novo Nordisk Pharma, Inc.
Country: United States (US)
ATC code: A10AD05
ATC class: Insulin aspart
Defined daily dose: 40 E, P
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: June 3, 2026

Packs & prices · 1

ndc11
7307020315
5 SYRINGE, PLASTIC in 1 CARTON (73070-203-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-203-10)

Regulatory notes

UNII (FDA substance ID)

D933668QVX

INSULIN ASPART

RxCUI 51428

DailyMed SPL labels

1 version tracked

FDA shortage

Currently in shortage

Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension

Interactions

434 interactions on record for insulin aspart.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check insulin aspart against other medicines How interaction checks work

Insulin aspart · interactions on record

434 records

15 severe
368 moderate
50 minor

Most severe, free to view

SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate
PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Insulin aspart in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin aspart products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Dazparda, Fiasp
Liechtenstein · Dazparda, Insulin Aspart Sanofi
Norway · Dazparda, Fiasp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e5aeecb2-6e99-4bd4-b150-2bc1c3d689ca
GET /v1/drugs/e5aeecb2-6e99-4bd4-b150-2bc1c3d689ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "D933668QVX",
    "rxcui": "51428",
    "inchikey": null,
    "display_name": "INSULIN ASPART",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "SUBCUTANEOUS",
  "spl_meta": {
    "5d9f0e10-edb9-4960-bd62-cf406e75bbe7": {
      "match": "brand_token",
      "title": "INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [REMEDYREPACK INC.]",
      "spl_version": "9",
      "published_date": "2026-04-08"
    }
  },
  "productid": "73070-203_ec67820c-4008-4894-b933-34b28704221d",
  "productndc": "73070-203",
  "dosage_form": "INJECTION, SUSPENSION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "INSULIN ASPART",
  "shortage_reason": "Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension",
  "shortage_status": "current",
  "proprietary_name": "Insulin Aspart Protamine and Insulin Aspart",
  "active_ingred_unit": "[iU]/mL",
  "application_number": "BLA021172",
  "marketing_category": "BLA",
  "nonproprietary_name": "insulin aspart",
  "start_marketing_date": "20020911",
  "active_numerator_strength": "100"
}

API reference MCP server Plans

See everything about insulin aspart.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console